East/West CEO
Date: Location: Cost:
January 6 - 7, 2018 Four Seasons Hotel
757 Market Street
San Francisco, CA 94103
(415) 633-3000

Starting at $1950


Dress Code:
Business Attire


EAST/WEST CEO – January 6, 2018 - DRAFT

Time Agenda
8:00-9:00 am

Registration and Networking Breakfast

9:00-9:30 am

Welcoming Remarks

9:30-10:00 am

Building a Biotech: Innovative Business Models
Punit Dhillon, CEO, Oncosec Medical; Kevin Judice, CEO, DiCE Molecules; Hamza Suria, President & CEO, AnaptysBio
Moderator: Ron Cooper, President & CEO, Albireo Pharma

10:00-10:30 am

Private Company Perspectives on Raising Capital and Partnering
Brian Frenzel, President & CEO, Tosk; Ivana Magovcevic-Liebisch, EVP, Chief Strategic & Corporate Development Officer, Axcella Health; Russ Herndon, President & CEO, Hydra Biosciences; Wendye Robbins, President & CEO, Blade Therapeutics; Leslie Williams, Director, Founder, CEO, & President, ImmusanT
Moderator: Donald NicholsonCEO, Nimbus Therapeutics

10:30-11:00 am

Funding Innovation While Balancing Risk: The VC Perspective
Bernard Davitian, VP & Managing Director, Sanofi-Genzyme Bioventures; Ken HaasPartner, Abingworth; Charlotte Hubbert, Partner, Bill & Melinda Gates Foundation; Art Pappas, Managing Partner, Pappas Ventures
Moderator: Bob Carey, EVP, CBO, Horizon Pharma

11:00-11:30 am

Media Perspectives on 2017; View Towards 2018

11:30-12:00 pm

Large Biotech and Pharma Perspectives: Takeaways from Last Year
Gilmore O'Neil, SVP, Drug Innovation, Biogen; Shafique Virani, VP & Global Head, Partnering NORD, Roche
Moderator: Jeremy Goldberg, Managing Director, Torreya Partners

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Ensuring Diversity and Inclusion 
Annalisa Jenkins, President & CEO, Dimension Therapeutics; Meredith Miller, Chief Corporate Governance Officer, UAW Retiree Medical Benefits Trust
Moderator: Marianne De BackerVP, Venture Investments, Johnson & Johnson

1:30-2:00 pm

Global Markets: Biotech Access Across Borders
Luigi Costa, CEO, Nordic Nanovector ASA; Samantha Du, Chairman & CEO, Zai Laboratory; Carl Firth, CEO, Aslan Pharmaceuticals; Mark Rothera, Chief Commerical Officer, PTC Therapeutics; Daniel Welch, Executive Partner, Sofinnova Ventures
Moderator: Luc Dochez, CEO, Tusk Therapeutics

2:00-2:30 pm

Accessing Innovation in Drug Discovery
Katherine Bowdish
, VP, Global R&D; Head, Sunrise Ventures, Sanofi; Michael Hayden, CSO & President, Global R&D, Teva; Martin Mackay, EVP; Head, R&D, Alexion; David MollerSVP, BD, Emerging Technology & Innovation, Eli Lilly; Sam Waksal, Founder, MeiraGtx
Moderator: Robert Urban, Global Head, Johnson & Johnson Innovation

2:30-2:50 pm

Fireside Chat

2:50-3:20 pm

Networking Break

3:20-3:50 pm

New Trends in Oncology & Immunotherapy
Helmy Eltoukhy, CEO, Guardant Health; Axel Hoos, SVP, Head, Oncology R&D, Head, IO, GlaxoSmithKline; Arthur Krieg, CEO & Founder, Checkmate Pharmaceuticals; Pascal Touchon, Global Head, Strategy & BD, Novartis Oncology

3:50-4:20 pm

Trends in Private Financing: Will the Capital Continue?
Rinko Ghosh, President & CBO, Symic Bio; Shalabh Gupta, President & CEO, Globavir; Robert Nelsen, Managing Director & Co-Founder, ARCH Venture Partners; Stephen Worland, President & CEOeFFECTOR Therapeutics

4:20-4:50 pm

Healthcare Market Outlook: Predictions for 2017
Leena Das-Young, Head, Late Phase Strategy & Development, Pfizer; Sara RadcliffeCEO, CALifeSciences; Melinda RichterHead, Johnson & Johnson Innovation, JLABS; Allan Shaw, CFO, Syndax Pharmaceuticals
Moderator: Arthur HillerCEO, Antyllus

4:50-6:00 pm

Cocktails and Hors d'oeuvres

January 7, 2018

Time Agenda
7:00-8:00 am

Registration and Networking Breakfast

8:00-8:20 am

Welcoming Remarks

8:20-8:50 am

Global Perspectives on Funding and Innovation
Ken Horne, CEO, Symic Bio; Brian McVeighVP, WWBD Transactions & Investment Management, GlaxoSmithKline; Timothy Walbert, Chairman, President, & CEO, Horizon Pharma

8:50-9:20 am

State of the Healthcare Industry: Building a Sustainable Future
Kevin Gorman, President & CEO, Neurocrine Biosciences; Bill Hait, Global Head, Janssen Research & Development, LLC; Jeff Jonker, President, NGM Bio; Sean McCarthy, President & CEO, CytomX; Bill Newell, CEO, Sutro Biopharma
Moderator: Philippe Lopes-FernandesSVP, Global Head, BD & Alliance Management, EMD Serono

9:20-9:40 am

Fireside Chat

9:40-10:10 am

Networking Break

10:10-10:40 am

Small-Cap and Private Biotech: Leveraging Potential
John Alam, CEO, EIP Pharma; Julie Eastland, CFO, Cascadian Therapeutics; Linda Grais, CEO, Ocera Therapeutics; Robert Wills, Executive Chairman, GTx
Moderator: Edward KayePresident, CEO, & CMO, Sarepta

10:40-11:10 am

Mid-Cap Biotech: Challenges and Opportunities
Alan Ezekowitz, CEO, Abide Therapeutics; Paul Grint, President & CEO, Regulus Therapeutics; Joe PaynePresident & CEO, Arcturus Therapeutics; Neil Warma, CEO, Opexa Therapeutics
Moderator: Robert Forrester, President & CEO, Verastem

11:10-11:40 am

CFO Disrupters in Biotech

11:40-12:10 pm

Biotech Partnering: Strategies for Success
Paul Biondi, SVP; Head, BD, Bristol-Myers Squibb; Samarth Kulkarni, CBO, CRISPR; John DeYoung, VP, WWBD, Pfizer; Henry Gosebruch, EVP, Chief Strategy Officer, AbbVie; Jay Luly, CEO, Enanta

12:10-1:10 pm

Networking Lunch

1:10-1:30 pm

Fireside Chat

1:30-2:00 pm

Venture Philanthropy and Entrepreneurship: Advancing Medical Innovation
Marc Cohen, Executive Chairman, C4 Therapeutics; John Mendlein, CEO & Director, aTyr Pharma; Michael Sneed, WWVP, Global Corporate Affairs, Chief Communication Officer, Johnson & Johnson; Steve Tregay, CEO, FORMA Therapeutics
Moderator: Jennifer Wheler, Senior Medical Director, Novartis

2:00-2:30 pm

Evolving Biopharma Boards
Martin Babler, CEO, Principia Biopharma; William Heiden, CEO, AMAG Pharmaceuticals; Nancy Lurker, President & CEO, pSivida; Robert Overell, President & CEO, Phase Rx; Catherine Sohn, Chairman, BioEclipse Therapeutics
Moderator: Deborah DunsireCEO, Southern Cross Biotech

2:30-3:00 pm

Networking Break

3:00-3:30 pm

R&D Trends: What's Changed in the Pharma Pipeline?
Tom HeymanPresident, Johnson & Johnson Innovation, JJDC; Vivek Ramaswamy, CEO, Roivant Sciences and Axovant Sciences; Daniel Teper, CEO, Immune Pharmaceuticals

3:30-3:50 pm

Moderated Keynote

3:50-4:00 pm

Presentation of Lifetime Achievement Award
Tom Heyman, 2017 Honoree; David Pyott, 2016 Honoree; Paul Stoffels, 2014 Honoree

4:00-5:00 pm

Cocktails and Hors d'oeuvres

Executive Sponsors: (see all sponsors)